1. Home
  2. MYNZ vs LRHC Comparison

MYNZ vs LRHC Comparison

Compare MYNZ & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • LRHC
  • Stock Information
  • Founded
  • MYNZ 2021
  • LRHC 2004
  • Country
  • MYNZ Germany
  • LRHC United States
  • Employees
  • MYNZ N/A
  • LRHC N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • LRHC
  • Sector
  • MYNZ Health Care
  • LRHC
  • Exchange
  • MYNZ Nasdaq
  • LRHC Nasdaq
  • Market Cap
  • MYNZ 7.2M
  • LRHC 6.7M
  • IPO Year
  • MYNZ 2021
  • LRHC 2023
  • Fundamental
  • Price
  • MYNZ $3.20
  • LRHC $0.15
  • Analyst Decision
  • MYNZ Buy
  • LRHC
  • Analyst Count
  • MYNZ 2
  • LRHC 0
  • Target Price
  • MYNZ $14.00
  • LRHC N/A
  • AVG Volume (30 Days)
  • MYNZ 105.1K
  • LRHC 20.2M
  • Earning Date
  • MYNZ 05-06-2025
  • LRHC 04-15-2025
  • Dividend Yield
  • MYNZ N/A
  • LRHC N/A
  • EPS Growth
  • MYNZ N/A
  • LRHC N/A
  • EPS
  • MYNZ N/A
  • LRHC N/A
  • Revenue
  • MYNZ $893,991.00
  • LRHC $69,448,786.00
  • Revenue This Year
  • MYNZ $42.95
  • LRHC N/A
  • Revenue Next Year
  • MYNZ N/A
  • LRHC N/A
  • P/E Ratio
  • MYNZ N/A
  • LRHC N/A
  • Revenue Growth
  • MYNZ N/A
  • LRHC 118.67
  • 52 Week Low
  • MYNZ $0.18
  • LRHC $0.09
  • 52 Week High
  • MYNZ $8.20
  • LRHC $3.36
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 40.90
  • LRHC 42.67
  • Support Level
  • MYNZ $3.03
  • LRHC $0.09
  • Resistance Level
  • MYNZ $3.31
  • LRHC $0.22
  • Average True Range (ATR)
  • MYNZ 0.35
  • LRHC 0.03
  • MACD
  • MYNZ 0.06
  • LRHC -0.00
  • Stochastic Oscillator
  • MYNZ 61.80
  • LRHC 46.29

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About LRHC La Rosa Holdings Corp.

La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has five reportable segments namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management and Real Estate Brokerage Services (Commercial). It derives maximum revenue from Real Estate Brokerage Services (Residential) segment.

Share on Social Networks: